After following 200 consecutive new patients aged 50 and older who presented with cognitive symptoms, they found that a simple blood test measuring p-tau217 significantly improved diagnostic accuracy in routine clinical practice.
When relying solely on standard clinical evaluation, doctors correctly diagnosed Alzheimer’s in 75.5% of cases, but when incorporating blood test results, diagnostic accuracy increased to 94.5%. The findings are published in the Journal of Neurology.